Related Experiment Videos
Antisense effects of DNA-peptide conjugates
Takanori Kubo1, Rumiana Bakalova, Hideki Ohba
1Department of Biological and Environmental Chemistry, Kyushu School Engineering, Kinki University, 11-6 Kayanomori, Iizuka, Fukuoka 820-8555, Japan.
Nucleic Acids Research. Supplement (2001)
|September 27, 2003
Summary
Novel antisense conjugate DNAs show significantly enhanced inhibition of human telomerase compared to traditional forms. These conjugates demonstrate improved cellular uptake and targeted localization, offering a promising therapeutic strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oligonucleotide Therapeutics
Background:
- Human telomerase is a key target for cancer therapy.
- Antisense DNA strategies face challenges in cellular uptake and stability.
- Conjugation of DNA with functional peptides can potentially enhance therapeutic efficacy.
Purpose of the Study:
- To synthesize and characterize novel antisense conjugate DNAs.
- To evaluate the inhibitory effects of these conjugates on human telomerase activity.
- To assess the cellular uptake and intracellular localization of the synthesized conjugates.
Main Methods:
- Solid-phase fragment condensation (SPFC) for synthesizing DNA conjugates.
- Telomerase repeat amplification protocol (TRAP) assay for evaluating telomerase inhibition.
- Confocal fluorescent microscopy for observing cellular uptake and localization.
Main Results:
- Antisense conjugate DNAs exhibited significantly higher telomerase inhibitory activity than native antisense DNA in cell lysis.
- Conjugates showed comparable or superior inhibition to phosphorothioate DNA (S-DNA).
- In a cellular system, antisense conjugate DNAs demonstrated markedly enhanced inhibition compared to native or S-DNA.
Conclusions:
- Antisense conjugate DNAs represent a potent class of telomerase inhibitors.
- Conjugation enhances cellular uptake and intracellular localization, improving therapeutic potential.
- These findings support the development of conjugate DNAs as a novel anti-cancer strategy targeting telomerase.